세계의 피부과 치료제 시장 규모는 2034년까지 CAGR 10.5%를 나타낼 것으로 예측됩니다.
세계의 인구 고령화가 전례 없는 페이스로 진행되고 있는 가운데, 피부과 치료제 시장은 대폭적인 확대가 전망되고 있습니다. 세계보건기구(WHO)에 따르면 2050년까지 고령자의 80%가 중저소득국에 거주하게 된다고 합니다. 고령화의 급속한 가속은 과거의 동향을 웃도는 것이며, 이것이 중요한 추진 인자가 될 전망입니다. WHO에 따르면 2030년까지 6명 중 1명이 60세 이상이 된다고 합니다. 또한 2021년부터 2050년까지 아시아에서는 65세 이상의 인구가 5억명 이상 증가해 피부과 치료제 시장이 급증할 전망입니다. 이 인구 역학의 변화는 주름, 얼룩, 노인들에게 많은 피부 질환과 같은 노화와 관련된 피부과적 고민에 맞는 피부 관리 솔루션에 대한 수요 증가를 의미합니다. 그러므로, 노년 인구의 확대에 대한 요구가 원동력이 되고, 앞으로 수년간은 피부과 치료제 업계에 유리한 시대가 될 것이라고 생각되고 있습니다.
역동적인 피부 과학의 상황에서 약물전달의 최첨단 기술의 통합은 시장을 전례없는 높이로 밀어 올리는 기세입니다. 나노기술의 출현은 피부세포의 정확한 타겟팅을 가능하게 하고, 부작용을 최소화하면서 피부과 치료제의 효능을 높일 수 있습니다. 이 획기적인 접근법은 보다 맞춤화되고 효율적인 치료를 보장하고 환자의 결과와 만족도를 높입니다. 마이크로니들 기술은 피부과 치료제의 투여를 재구성합니다. 이러한 저침습 장치는 통증 없이 피부를 관통하여 치료제의 제어된 지속 방출을 촉진합니다. 이는 환자의 컴플라이언스를 향상시킬 뿐만 아니라 약물 흡수를 최적화하고 보다 빠르고 효과적인 결과를 제공합니다.
본 보고서에서는 세계의 피부과 치료제 시장을 조사했으며, 시장 개요, 시장 성장에 미치는 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 보고서 개요
제2장 주요 요약
제3장 시장 개요
주요 조사 결과
시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
COVID-19의 영향 분석
Porter's Five Forces 분석
PEST 분석
제4장 피부과 치료제 시장 분석 : 투여 경로별
주요 조사 결과
시장 매력도 지수
시장 규모 추이 및 예측
국소
경구
비경구
시장 규모 추이 및 예측 : 지역별
시장 점유율 : 지역별
제5장 피부과 치료제 시장 분석 : 질환별
주요 조사 결과
시장 매력도 지수
시장 규모 추이 및 예측
건선
피부염
여드름
피부 감염증
기타
시장 규모 추이 및 예측 : 지역별
시장 점유율 : 지역별
제6장 피부과 치료제 시장 분석 : 처방 모드별
주요 조사 결과
시장 매력도 지수
시장 규모 추이 및 예측
처방약
시판약(OTC)
시장 규모 추이 및 예측 : 지역별
시장 점유율 : 지역별
제7장 피부과 치료제 시장 분석 : 유통 채널별
주요 조사 결과
시장 매력도 지수
시장 규모 추이 및 예측
소매 약국
병원 약국
온라인 약국
기타
시장 규모 추이 및 예측 : 지역별
시장 점유율 : 지역별
제8장 피부과 치료제 시장 분석 : 지역별
주요 조사 결과
시장 규모 추이 및 예측
제9장 북미의 피부과 치료제 시장 분석
제10장 유럽의 피부과 치료제 시장 분석
제11장 아시아태평양의 피부과 치료제 시장 분석
제12장 라틴아메리카의 피부과 치료제 시장 분석
제13장 중동 및 아프리카의 피부과 치료제 시장의 분석
제14장 기업 프로파일
경쟁 구도
전략적 전망
Novartis AG
Bayer AG
LEO Pharma A/S
Pfizer Inc.
Johnson &Johnson Services, Inc.
Regeneron Pharmaceuticals Inc.
AbbVie Inc.
Verrica Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Roivant Sciences Ltd.
DermBiont, Inc.
AstraZeneca
Merck &Co., Inc.
GSK plc
F. Hoffmann-La Roche Ltd
Mayne Pharma Group Limited
제15장 총론 및 권장 사항
Visiongain에 의한 총론
참가 기업을 위한 추천 사항
AJY
영문 목차
영문목차
The global Dermatological Drugs Market is projected to grow at a CAGR 10.5% by 2034
The Dermatological Drugs Market Report 2024-2034: This report is essential for prominent enterprises seeking fresh revenue opportunities, aiming to enhance their comprehension of the industry and its inherent dynamics. It provides valuable insights for firms interested in diversifying across various sectors or expanding their current activities into new geographical areas.
Geriatric Population Driving Demand for Dermatological Drugs
As the global population ages at an unprecedented pace, the dermatological drugs market is poised for a significant upswing. According to the World Health Organization (WHO), by 2050, 80% of older individuals will reside in low- and middle-income countries. The rapid acceleration in population aging, outpacing historical trends, is a key catalyst. As per WHO, by 2030, one in every 6 person will be aged 60 or over. Also, from 2021 to 2050, population aged over 65 in Asia will grow by more than half-a-billion, creating a burgeoning market for dermatological drugs. This demographic shift signifies an increased demand for skincare solutions tailored to age-related dermatological concerns, such as wrinkles, age spots, and skin conditions prevalent in the elderly. Thus, the coming years will mark a lucrative era for the dermatological drugs industry, driven by the unique needs of the expanding geriatric population.
Nanotechnology in Drug Delivery Could Revolutionize the Dermatological Drugs Market
In the dynamic landscape of dermatology, the integration of cutting-edge technological advancements in drug delivery is poised to propel the market to unprecedented heights. The advent of nanotechnology enables precise targeting of skin cells, enhancing the efficacy of dermatological drugs while minimizing side effects. This revolutionary approach ensures a more tailored and efficient treatment, boosting patient outcomes and satisfaction. Micro-needle technology is reshaping the administration of dermatological drugs. These minimally invasive devices painlessly penetrate the skin, facilitating controlled and sustained release of therapeutic agents. This not only improves patient compliance but also optimizes drug absorption, leading to quicker and more effective results. Several companies are actively researching and developing nanocarriers and smart delivery systems for skincare applications such as NanoVibronix (US) and Nanologica (Sweden).
Furthermore, the incorporation of smart polymers in drug formulations represents a paradigm shift in dermatological treatments. These polymers respond to specific physiological cues, releasing drugs at the right time and in the right amounts. This precision enhances therapeutic outcomes, reduces the frequency of application, and minimizes adverse reactions.
What Questions Should You Ask before Buying a Market Research Report?
How is the Dermatological Drugs market evolving?
What is driving and restraining the Dermatological Drugs market?
How will each Dermatological Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each Dermatological Drugs submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading Dermatological Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the Dermatological Drugs projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of Dermatological
Drugs projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Dermatological Drugs market?
Where is the Dermatological Drugs market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Dermatological Drugs market today, and over the next 10 years:
Our 280-page report provides 113 tables and 160 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Dermatological Drugs market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Dermatological Drugs prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report
Route of Administration
Topical
Oral
Parenteral Administration
Disease
Psoriasis
Dermatitis
Acne
Skin Infections
Others
Prescription Mode
Prescription Drugs
Over-the-Counter (OTC) Drugs
Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the Dermatological Drugs Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
AbbVie Inc.
AstraZeneca
Bayer AG
DermBiont, Inc.
F. Hoffmann-La Roche Ltd
GSK plc
Johnson & Johnson Services, Inc.
LEO Pharma A/S
Mayne Pharma Group Limited
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Roivant Sciences Ltd.
Teva Pharmaceutical Industries Ltd.
Verrica Pharmaceuticals
Overall world revenue for Dermatological Drugs Market, 2024 to 2034 in terms of value the market will surpass US$30.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Dermatological Drugs Market, 2024 to 2034 report help you?
In summary, our 280-page report provides you with the following knowledge:
Revenue forecasts to 2034 for Dermatological Drugs Market 2024 to 2034, with forecasts for route of administration, disease, prescription mode, and distribution channel each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 21 key national markets - See forecasts for the Dermatological Drugs Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the Dermatological Drugs Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Dermatological Drugs Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Dermatological Drugs Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Skin Disorders
3.2.1.2 Growing Awareness and Patient Education
3.2.1.3 Globalization and Urbanization
3.2.1.4 Revolutionizing Dermatology: Unleashing Market Growth Through Advanced Drug Delivery Technologies
